|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Semm bone r-carboxyglu tamic acid protein in a longitudinal study of infants显示文摘 | Michalsen KF Johansen JS Samuelson G | 1992 | Pediatr Res1992，31，： | 1 |
| 2 | High plasma YKL-40 level in patients with ovarian cancer stage Ⅲ is related to shorter survival 显示文摘 | Hogdall EV Johansen JS Kjoer SK | 2003 | Oncol Rep2003，10，5： | 1 |
| 3 | Is YKL-40 a new therapeutic target in cancer 显示文摘 | Johansen JS Jensen BV Roslind A | 2007 | Expert Opin Ther Targets2007，11，： | 1 |
| 4 | Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes:role of endothelin-1显示文摘 | Ergul A Johansen JS Stromhaug C | 2005 | Pharmacol Exp Ther2005，313，： | 1 |
| 5 | Plasma YKL-40 and total and disesse-specific mortality in the general population 显示文摘 | Johansen JS Bojesen SE Price PA | 2010 | Clin Chem2010，56，10： | 1 |
| 6 | Serum YKL-40,a potential new marker of disease activity in patients with inflarmmatory bowel disease显示文摘 | Johansen JS Price PA | 2003 | Stand J Gastroenterol2003，38，6： | 1 |
| 7 | Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links显示文摘 | Uebelhart D Schlemmer A Johansen JS | 1991 | J Clin Endoerinol Metab1991，72，： | 1 |
| 8 | Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer 显示文摘 | Dehn H Hogdall EV Johansen JS | 2003 | Acta Obstec Gynecol Scand2003，82，3： | 1 |
| 9 | Plasma YKL-40:a BMI independent marker of type 2 diabetes显示文摘 | Nielsen AR Erikstrup C Johansen JS | 2008 | Diabetes2008，57，11： | 1 |
| 10 | Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer 显示文摘 | Dehn H Hcgdall EV Johansen JS | 2003 | Acta Obstet Gynecol Scand2003，82，3： | 1 |
| 11 | Regulation of YKL-40 production by human articular chondrocytes显示文摘 | Johansen JS Olee T Price PA | 2001 | Arthritis Rheum2001，44，4： | 1 |
| 12 | High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival 显示文摘 | Hcgdall EV Johansen JS Kjaer SK | 2003 | Oncol Rep2003，10，5： | 1 |
| 13 | Identification of pro- teins secreted by human osteoblastic cells in culture 显示文摘 | Johansen JS Williamson MK Rice JS | 1992 | J Bone Min- er Res1992，7，5： | 1 |
| 14 | Pretreatment predic- tion of chemoresistance in second-line chemotherapy of ovarian car- cinoma:value of serological tumor marker determination (tetranec- tin, YKL-40, CASA, CA125 ) 显示文摘 | Gronlund B Hogdall EV Johansen JS | 2006 | Int J Biol Markers2006，21，2： | 1 |
| 15 | Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, {ihroses and cancer 显示文摘 | Johansen JS | 2006 | Dan Med Bull2006，53，2： | 1 |
| 16 | Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer 显示文摘 | Dehn H Hogdall EV Johansen JS | 2003 | Acta Obstet Gynecol Scand2003，82，： | 1 |
| 17 | Serum YKL-40, a new prognostic biomarker in cancer patients 显示文摘 | Johansen JS Jensen BV Roslind A | 2006 | Cancer Epidemiol Biomarkers Prev2006，15，2： | 1 |
| 18 | A new biochemical marker for joint injury: analysis of YKL-40 in serum and synovial fluid显示文摘 | Johansen JS Jensen HS Price PA | 1993 | Br J Rheumatol1993，32，： | 1 |
| 19 | YKL-40,a mammalian member of the chitinase family,is a matrix protein of specific granules in human neutrophils显示文摘 | Volck B Price PA Johansen JS | 1998 | Proc Assoc Am Physicians1998，0，4： | 1 |
| 20 | High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer显示文摘 | JOHANSEN JS PRICE PA | 2003 | Clin Cancer Res2003，9，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员